Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate Transdermal System (MTS)

MTS is an advanced patch product that provides methylphenidate evenly mixed with the adhesive. This formulation allows good adhesion and a wide range of dose sizes. MTS patch sizes of 12.5, 18.75, 25 and 37.5cm2 are equivalent to nominal doses over a 9-hour wear time of 10, 15, 20 and 30mg of MPH.

OTHER

placebo patch

This patch is designed to appear identical to the actual intervention patch

Trial Locations (1)

84132

University of Utah School of Medicine, Department of Psychiatry, Mood Disorders Clinic, Salt Lake City

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

University of Utah

OTHER